NHI
National Health Investors Inc.
$76.21
-$0.21(-0.27%)
65
Overall
100
Value
50
Tech
47
Quality
Market Cap
$3.41B
Volume
423.93K
52W Range
$68.80 - $91.38
Target Price
$87.13
Order:
Income Statement
| Metric | Trend | Chart | 2020 Sep | 2020 Dec | 2021 Mar | 2021 Jun | 2021 Sep | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $84.3M | $307.2M | $74.7M | $68.4M | $73.8M | $298.7M | $35.8M | $48.8M | $54.4M | $80.1M | ||
| Total Revenue | $84.3M | $332.8M | $74.7M | $68.4M | $73.8M | $298.7M | $278.2M | $319.8M | $335.2M | $375.6M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | $11.2M | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $84.3M | $332.8M | $74.7M | $68.4M | $73.8M | $298.7M | $278.2M | $319.8M | $335.2M | $375.6M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $27.8M | $161.8M | $31.1M | $27.9M | $49.5M | $216.1M | $241.9M | $200.9M | $211.9M | $239.0M | ||
| Selling, General & Administrative | $2.8M | $13.3M | $8.0M | $3.6M | $3.6M | $18.4M | $32.6M | $30.8M | $91.8M | $37.9M | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | -- | -- | -- | -- | $59.9M | -- | ||
| General & Administrative Expenses | $2.8M | $13.3M | $8.0M | $3.6M | $3.6M | $18.4M | $32.6M | $30.8M | $31.9M | $37.9M | ||
| Salaries & Wages | $-457.0K | -- | $-5.4M | $-992.0K | $-989.0K | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $20.8M | $83.2M | $20.8M | $20.7M | $20.0M | $80.8M | $70.9M | $70.0M | $71.4M | $57.4M | ||
| Depreciation & Amortization | $20.8M | $83.2M | $20.8M | $20.7M | $20.0M | $80.8M | $70.9M | $70.0M | $71.4M | $57.4M | ||
| Amortization | -- | -- | $-260.0K | $-262.0K | -- | -- | -- | -- | -- | $57.4M | ||
| Other Operating Expenses | $4.2M | -- | $2.3M | $3.6M | $25.9M | $-14.6M | $16.7M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-27.8M | $-96.5M | $43.6M | $40.5M | $-49.5M | $-99.2M | $-67.6M | $-52.0M | $-37.4M | $-96.1M | ||
| EBITDA | $111.5M | $326.9M | $69.2M | $85.7M | $98.2M | $248.2M | $184.7M | $266.8M | $271.7M | $281.6M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $12.9M | $52.9M | $13.0M | $12.8M | $12.7M | $50.8M | $44.9M | $58.2M | $59.9M | $57.4M | ||
| Interest Income Operating | $6.5M | $25.6M | $6.1M | $6.0M | $6.8M | $27.7M | $24.7M | $21.8M | $23.7M | $24.0M | ||
| Intinc | -- | -- | -- | -- | -- | -- | -- | $14.7M | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-12.9M | $-52.9M | $-13.0M | $-12.8M | $-12.7M | $-50.8M | $-44.9M | $-58.2M | $-59.9M | $-57.4M | ||
| Gain on Sale of Securities | -- | -- | -- | $6.5M | -- | $-7.3M | -- | -- | $6.3M | -- | ||
| Other Income/Expense | $-77.1M | $-321.5M | $1.3M | $-5.6M | $-86.4M | $-300.4M | $-245.8M | $-191.6M | $-263.7M | $-275.7M | ||
| Other Special Charges | $77.8M | $324.6M | $-451.0K | -- | $67.0M | $302.0M | $217.5M | $249.2M | $257.0M | $271.6M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | $-241.0K | $-1.3M | $-130.0K | $40.0K | $-117.0K | $-908.0K | $-2.6M | $202.0K | $6.7M | $-1.6M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $45.4M | $238.2M | $48.4M | $41.7M | $33.3M | $162.8M | $110.4M | $192.5M | $196.5M | $198.2M | ||
| Pre-Tax Income | $42.7M | $196.5M | $35.4M | $39.2M | $30.8M | $177.2M | $157.9M | $176.1M | $185.3M | $202.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $42.6M | $185.1M | $35.3M | $39.2M | $30.8M | $111.8M | $66.4M | $135.7M | $138.0M | $142.2M | ||
| Net Income (Continuing Operations) | $42.6M | $185.3M | $35.3M | $39.2M | $30.8M | $112.0M | $65.5M | $134.4M | $136.6M | $140.8M | ||
| Net Income (Discontinued Operations) | $42.6M | $185.1M | $35.3M | $39.2M | $30.8M | $111.8M | $66.4M | $135.7M | $138.0M | $142.2M | ||
| Net Income (Common Stockholders) | $42.6M | $185.1M | $35.3M | $39.2M | $30.8M | $111.8M | $66.4M | $135.6M | $137.9M | $142.0M | ||
| Normalized Income | -- | $156.5M | -- | -- | -- | $140.9M | $97.1M | -- | -- | $282.1M | ||
| TOTALS | ||||||||||||
| Total Expenses | $27.8M | $161.8M | $31.1M | $27.9M | $49.5M | $216.1M | $241.9M | $200.9M | $211.9M | $239.0M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $44.7M | $44.7M | $45.3M | $45.9M | $45.9M | $45.7M | $44.8M | $43.4M | $43.8M | $46.9M | ||
| Average Shares Outstanding (Diluted) | $44.7M | $44.7M | $45.4M | $45.9M | $45.9M | $45.7M | $44.8M | $43.4M | $44.1M | $47.1M | ||
| Shares Outstanding | $44.7M | $45.2M | $45.9M | $45.9M | $45.9M | $45.9M | $43.4M | $43.4M | $45.7M | $48.4M | ||
| Basic EPS | $0.95 | $4.14 | $0.78 | $0.85 | $0.67 | $2.45 | $1.48 | $3.13 | $3.14 | $3.03 | ||
| Basic EPS (Continuing Operations) | -- | $4.14 | -- | -- | -- | $2.45 | $1.48 | $3.13 | $3.14 | $3.03 | ||
| Diluted EPS | $0.95 | $4.14 | $0.78 | $0.85 | $0.67 | $2.44 | $1.48 | $3.13 | $3.13 | $3.02 | ||
| Diluted EPS (Continuing Operations) | -- | $4.14 | -- | -- | -- | $2.44 | $1.48 | $3.13 | $3.13 | $3.02 | ||
| Dividend Per Share | $1.1 | $4.41 | $1.1 | $0.90 | $0.90 | $3.8 | $3.6 | $3.6 | $3.6 | $3.64 | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | $57.0K | $118.0K | $201.0K | ||
| Acquired In Process Rn D | -- | -- | -- | -- | -- | -- | -- | -- | $6.7M | -- | ||
| Acquired In Process Rn D Income | -- | -- | -- | -- | -- | $32.5M | $28.3M | -- | -- | $456.0K | ||
| Acquisition Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $80.9M | ||
| Earnings from equity interest | $-728.0K | $-3.1M | $-800.0K | $-909.0K | $19.4M | $-1.5M | $569.0K | $555.0K | $402.0K | $3.7M | ||
| Earnings From Equity Interest Net Of Tax | $-728.0K | $-3.1M | $-800.0K | $-909.0K | $19.4M | $-1.5M | $569.0K | $555.0K | $402.0K | $3.7M | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | $-710.0K | $20.0K | -- | -- | ||
| Insurance And Claims | -- | -- | -- | -- | -- | -- | $9.8M | $11.5M | $11.2M | $11.0M | ||
| Interest Expense Operating | $-10.1M | -- | $-10.5M | $-10.4M | $-10.2M | $-40.0K | $-46.0K | $-90.0K | $-193.0K | -- | ||
| Loss And Loss Adjustment Expected Incurred | -- | -- | $90.0K | -- | -- | -- | -- | -- | $71.4M | -- | ||
| Marketing Expense | -- | -- | -- | -- | -- | -- | -- | -- | $59.9M | -- | ||
| Minority Interests | $-66.0K | $-185.0K | $-52.0K | $-48.0K | $-35.0K | $-163.0K | $902.0K | $1.3M | $1.3M | $1.4M | ||
| Non Recurring Operation Expense | $241.0K | $1.3M | $130.0K | $-40.0K | $117.0K | $908.0K | $2.6M | -- | -- | $1.6M | ||
| Other Gand A | $2.8M | $13.3M | $8.0M | $3.6M | $3.6M | $18.4M | $32.6M | $30.8M | $31.9M | $37.9M | ||
| Other Write Off | -- | -- | -- | -- | -- | -- | -- | $58.2M | -- | -- | ||
| Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | $57.0K | $118.0K | $201.0K | ||
| Rent And Landing Fees | $2.8M | -- | $8.0M | $3.6M | $3.6M | -- | -- | -- | -- | -- | ||
| Write Down | -- | -- | -- | -- | -- | -- | -- | -- | $59.9M | -- | ||
| Othspecchg | -- | -- | -- | -- | -- | -- | -- | $-202.0K | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NHI | $76.21 | -0.3% | 423.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get National Health Investors Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW